OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
Sho Iketani, Seo Jung Hong, Jenny Sheng, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 10, pp. 1354-1362.e6
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012522-e1012522
Open Access | Times Cited: 3

Revealing SARS-CoV-2 Mpro Mutation Cold and Hot Spots: Dynamic Residue Network Analysis Meets Machine Learning
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 3

EvoAI enables extreme compression and reconstruction of the protein sequence space
Zi-yuan Ma, Wenjie Li, Yunhao Shen, et al.
Nature Methods (2024)
Open Access | Times Cited: 3

Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier
Liwei Zhao, Chuang Li, Mengyu Wang, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access

A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8

Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2
Vinícius Bonetti Franceschi, Erik Volz
Wellcome Open Research (2024) Vol. 9, pp. 85-85
Open Access | Times Cited: 2

Sierra SARS-CoV-2 sequence and antiviral resistance analysis program
Philip L. Tzou, Kaiming Tao, Malaya K. Sahoo, et al.
Journal of Clinical Virology (2022) Vol. 157, pp. 105323-105323
Open Access | Times Cited: 10

Rapid resistance profiling of SARS-CoV-2 protease inhibitors
Seyed Arad Moghadasi, Rayhan G. Biswas, Daniel A. Harki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
(2024)
Open Access | Times Cited: 1

Computational Insights into SARS-CoV-2 Main Protease Mutations and Nirmatrelvir Efficacy: The Effects of P132H and P132H-A173V
Yuan-Ling Xia, Wen-Wen Du, Yongping Li, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 13, pp. 5207-5218
Closed Access | Times Cited: 1

Molecular Dynamics Simulations Suggest SARS-CoV-2 3CLpro Mutations in Beta and Omicron Variants Do Not Alter Binding Affinities for Cleavage Sites of Non-Structural Proteins
Vitor Martins de Freitas Amorim, Robson Francisco de Souza, Cristiane Rodrigues Guzzo, et al.
COVID (2023) Vol. 3, Iss. 4, pp. 622-636
Open Access | Times Cited: 2

A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases
R. Leonard, Rao Vn, Alexandria Bartlett, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 1

Drug Susceptibility and the Potential for Drug-Resistant SARS-CoV-2 Emergence in Immunocompromised Animals
Maki Kiso, Ryuta Uraki, Seiya Yamayoshi, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110729-110729
Open Access

SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots
Pol Garcia‐Segura, Ariadna Llop-Peiró, Nil Novau-Ferré, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109344-109344
Open Access

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 825-852
Open Access

Rapid resistance profiling of SARS-CoV-2 protease inhibitors
Reuben S. Harris, Seyed Arad Moghadasi, Rayhan G. Biswas, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Backstage Heroes—Yeast in COVID-19 Research
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access

Lineage frequency time series reveal elevated levels of genetic drift in SARS-CoV-2 transmission in England
Qinqin Yu, Joao A. Ascensao, Takashi Okada, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Resistance mechanisms of SARS-CoV-2 3CLpro to the non-covalent inhibitor WU-04
Lijing Zhang, Xuping Xie, Hannan Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Previous Page - Page 2

Scroll to top